The vendor that used to be the customer: Pivot Path’s $27M spinout story
Every pharma CIO has sat through the same vendor pitch: a platform built by people who understand the idea of a regulated environment, but who have never actually owned a deviation, fronted an inspection, or explained a missing signature to an FDA auditor. Pivot Path breaks that pattern by inverting it. The company didn’t set out to build software for pharma companies — it set out to run pharmacovigilance, validation, and manufacturing IT inside Strides Pharma’s own regulated operations, and only became a vendor once its internal tools had already survived the audits, inspections, and quality reviews that every one of its future customers would eventually put it through.
Now spun out as an independent company, Pivot Path serves more than 70 pharma companies across five continents, generates INR 147 crore in revenue, is already profitable, and just raised INR 100 crore (roughly $12M) from Ascent Capital at a INR...
Copyright of this story solely belongs to expresscomputer.in. To see the full text click HERE
